Across TCGA pan-cancer cohorts, TMEM50A mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of TMEM50A’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where TMEM50A mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types TMEM50A is over-expressed in tumor.

LSCC and HNSC are the cancer types where TMEM50A tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TMEM50A mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	All	All	+0.317	<.001	5	view →
HNSC	All	All	+0.787	.002	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: TMEM50A RNA expression & survival · all TMEM50A data types